An Insight into Mucinous Ovarian Cancer
Mucinous ovarian cancer is a type of epithelial ovarian cancer that begins at the ovaries of a female and if left unattended to can even reaches other parts of the body like liver, lungs, breasts, brain and lymphatic nodes. They are most commonly found in women who are in the age range of 65 to 85 years, but can also be seen in women who are much younger. Mucinous ovarian cancer will lead to the improper functioning of the process of repair and reproduction of cells in the ovaries.
This will cause abnormal growth and division of the cells at uncontrollable speeds and finally a lump or a tumor is formed inside the ovaries. Mucinous ovarian cancer detected at an early stage has greater prognosis history and the survival rate of the patient affected by the mucinous ovarian cancer is very high. But it is not easy to detect the presence of mucinous ovarian cancer in women at its initial stage.
First line of Mucinous Ovarian Cancer treatment
The first line of treatment for mucinous ovarian cancer like any other cancer treatment is surgery. The surgery will be an attempt to physically remove the benign or malignant tumor caused in the female private area due to the presence of mucinous ovarian cancer. The normal surgical procedure to treat patients suffering from mucinous ovarian cancer is to remove the uterus, ovaries and fallopian tubes. Only by diagnosing the extent to which the mucinous ovarian cancer has spread in the patient’s body can a further treatment be suggested.
A woman who is interested in conceiving despite suffering from mucinous ovarian cancer will be allowed to remove the ovaries and the fallopian tubes and the uterus will not be touched by the surgeon. Another type of surgical procedure that is followed by surgeons who are treating female patients suffering from mucinous ovarian cancer is debunking procedure which simply means removing of all mucinous cancer tumors that are more than one centimeter.
Recurrent Mucinous Ovarian Cancer
If the recurrence of mucinous ovarian cancer is seen in a patient after a period of six months, then the disease is considered to be platinum resistant which implies that the disease is resistant to chemotherapy drugs. Now, it is time to try the secondary chemotherapy drugs on the patient to see if it is working and this can be only told after two to four courses have gone inside he patient. If this secondary chemotherapy medicine fails, then the only thing the surgeon could do is to find a medicine that will stem the growth of mucinous ovarian cancer further and keep the patient to be emotionally, mentally and physically comfortable.